Minerva Neurosciences
NASDAQ: NERV
NYSE
NYSE
Healthcare
Biotechnology
Global Rank
#38799
Country Rank
#4788
Market Cap
12.52 M
Price
1.79
Change (%)
3.24%
Volume
19,070
Minerva Neurosciences's latest marketcap:
12.52 M
As of 06/06/2025, Minerva Neurosciences's market capitalization has reached $12.52 M. According to our data, Minerva Neurosciences is the 38799th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 12.52 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 6.25 M |
| Shares Out | 6.99 M |
| EPS (ttm) | 0.83 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/05/2025 |
Market Cap Chart
Data Updated: 06/06/2025
Minerva Neurosciences's yearly market capitalization.
Minerva Neurosciences has seen its market value drop from $111 M to $12.52 M since 2014, representing a total decrease of 88.72% and an annual compound decline rate (CAGR) of 18.88%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 06/06/2025 | $12.52 M | -16.77% |
| 12/31/2024 | $15.5 M | -63.95% |
| 12/29/2023 | $43 M | 405.88% |
| 12/30/2022 | $8.5 M | -75.15% |
| 12/31/2021 | $34.2 M | -65.77% |
| 12/31/2020 | $99.9 M | -64% |
| 12/31/2019 | $277.5 M | 5.92% |
| 12/31/2018 | $262 M | 11.92% |
| 12/29/2017 | $234.1 M | -42.76% |
| 12/30/2016 | $409 M | 172.49% |
Company Profile
Minerva Neurosciences was founded in 2007 in United States.
The company went public on 07/01/2014
on the Nasdaq Stock Market.
With 8 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Minerva Neurosciences's (NERV) current market cap?As of 06/06/2025, Minerva Neurosciences (including the parent company, if applicable) has an estimated market capitalization of $12.52 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Minerva Neurosciences (NERV) rank globally by market cap?Minerva Neurosciences global market capitalization ranking is approximately 38799 as of 06/06/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.